Current members

Principal Investigator

Headshot of Dr. Gang Huang

Principal Investigator

Gang Huang, PhD

Professor, Kathryn Mays Johnson Distinguished Chair in Oncology

Dr. Gang Huang leads the Huang Lab at UT Health San Antonio, where the group studies cancer biology, hematology, metabolism, immunology, and translational product development.

His work spans fundamental mechanisms and commercialization pathways, including therapeutic programs emerging through spin-out companies.

Current members

Postdoctoral Scholar

Postdoctoral Scholar

Jie Bai, PhD

Postdoctoral Scholar

Dr. Bai contributes to the lab’s work on hematopoietic stem cells, cancer biology, and translational mechanisms.

Current members

Staff

Staff

Tian Li

Lab Manager

Tian Li supports lab operations, experimental workflows, and the day-to-day execution of research programs across the Huang Lab.

Staff

Yaxing Nie

Research Assistant, Senior

Yaxing Nie supports complex experimental and operational work across active Huang Lab research programs.

Current members

Student Researcher

Student Researcher

Kasie Liu

Undergraduate Research Assistant

Kasie Liu contributes to research support and student-driven projects within the lab’s broader translational science programs.

Student Researcher

Victoria Sanchez

Undergraduate Research Assistant

Victoria Sanchez contributes to research support within the Huang Lab’s cancer and metabolism programs.

Current members

Faculty

Faculty

Ya-Guang Liu, MD

Assistant Professor

Dr. Liu brings clinical and translational expertise that supports the lab’s efforts to move promising science toward real therapeutic impact.

Current members

Graduate Student

Headshot of Alejandra Lorenzen

Graduate Student

Alejandra Lorenzen

PhD Student

Alejandra Lorenzen is part of the lab’s graduate research community, contributing to the interdisciplinary study of cancer and metabolism.

Headshot of Vincent T. Pham

Graduate Student

Vincent T. Pham

PhD Candidate, Cancer Biology

Vincent Pham works on solid-tumor immunotherapy and translational programs within the lab, including PH102-related research and conference presentations.